PBYI FY 2013 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$305M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$55M

Net Income

-$55M

EPS (Diluted)

$-1.90

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$56M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$104M

Total Liabilities

$20M

Stockholders' Equity

$84M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$55M	-$74M	+26.3%
Net Income	-$55M	-$74M	+26.4%